Successful Biotech Investing: Every Investor’s Complete Guide
March 11, 2010 by biotechbillboard.com
Product Description
As the adage goes, “Invest in what you know.” Many investors have made fortunes in biotech stocks and funds—a very lucrative but risky sector. If you don’t have a medical background, how can you make intelligent picks in biotechnology?
With Successful Biotech Investing, understanding the science and business behind biotechnology is easy. Financial and medical expert Joe Duarte, M.D., masterfully guides you through the complicated world of biotech to show you how to avoid the risks and confidently choose the best stocks and funds for your portfolio. With up-to-date information on everything from vaccines, drugs, and gene manipulation to cloning, aging, and medical devices, this book demystifies the language, reveals the biotech business cycle, and separates the fads from the genuine technology. Inside, you will discover how to:
Grasp the science to understand—and profit from—new trends
Analyze companies for research, patents, growth potential, and more
Find the best biotech funds and index shares
Understand when to use biotech as a defensive and offensive play
And much more!
Dr. Duarte’s complete lessons teach you both the fundamental and technical analysis of biotech stocks, allowing you to pick the approach that matches your investment style. Detailed analyses on companies big and small, new and old, go behind the scenes to reveal emerging trends, groundbreaking research, and exploding profits. Complete with helpful charts and investment resources, this book is every investor’s guide to confidently investing in the biotech sector.
“The author’s combined knowledge of medicine, biotechnology, and market analysis comes through at a crucial time for the sector. Easy to read and equally easy to use.”—John Murphy, President, MurphyMorris.com
“If ever an industry needed deciphering, it’s biotechnology. Joe Duarte combines a knowledge of medicine with Wall Street smarts.” —Thom Calandra, Editor-in-Chief, CBS MarketWatch
“Dr. Duarte’s dual expertise in medicine and investing makes this an important book for potential investors.”—Leslie Kane, Senior Editor, Medical Economics
“A sound analytical approach to biotech investing.”—Mark A. Seleznov, Managing Partner, Trend Trader
“If your going to trade biotech stocks, start here!”—J. Michael Pinson Founder and Senior Analyst, MarketMavens.com
Buy from AMAZON Successful Biotech Investing: Every Investor’s Complete Guide
Since I’m not interested in being a PhD this seems like the perfect book for me and more than likely for the average investor. The thing I really like about this book is that it helps me know how to make money from the coming biotech explosion.
I don’t care how this stuff works nearly as much as how to build my net worth by investing. On that point, this is THE book. It has just about everything-understandable explanation of the industry, how to tell which companies are likely to be leaders, and even a reference database.
If I had a book this good at the beginning of the ‘high tech’ explosion I could have retired already. I would have understood enough about Oracle, Cisco, and all that lot to make even more money. I don’t intend to be on the back half of the next wave. I give this book five stars. Thanks a million, $$$, to the author.
Rating: 5 / 5
Dr. Duarte has put it all together in this book. The future of biotech stocks is incredible, but investing without a full understanding of the industry is risky. All the knowledge you need to invest successfully in biotech issues is right here!
Rating: 5 / 5
This book provides the average investor with a solid foundation in their pursuit of successful biotech investing.
Most investors invest in biotech stocks based on media exposure and momentum driven markets. There is a glaring lack of any sort of structure to their research or position management. Dr. Duarte’s book lays the groundwork for investors to establish a workable system of identifying and managing promising investments. By incorporating risk management techniques (technical analysis), he has provided a dose of reality to balance the inherent optimism the motivates biotech investors. This is crucial as it prevents the blow ups that destroy portfolios as well as investor confidence.
Rating: 5 / 5
The book looks great, but it is definitely not worth reading. If you are into technical analysis, you may derive some use from the text. However, I don’t see why you need a book devoted to biotech for investing on this basis.
There’s a weak chapter on the science (high school level at a stretch); a discussion on investment basics which misses the mark. The markets chapter is fine, but the review of major drug companies is weak. I just found the analysis of the biotech industry to be too weak. There’s simply too little analysis and too much opinion.
I have no idea why there’s a discussion on mutual funds. Unless the particular vehicle is a sector fund, the manager won’t start investing in biotech until the price has appreciated. By then, it’s too late.
The MD and CNBC credentials lead me to believe that this book would provide some dynamic insight or a systematic way for cutting through they hype. Sadly, it did neither.
Rating: 1 / 5
This book is far too basic for anyone who graduated high school biology. It is redundant, condecending, and very poorly edited.
Duarte’s explanations of scientific/ medical concepts are painfully dumbed down. (Admitedly, I too I am a physician, but I think anyone with even a remote scientific background would agree.)
Worse yet, much of the book is composed of generic and dated summaries of the major biopharma companies (not even an appropriate use of paper in the age of [investment websites]
I was hoping to learn from this book fundamental priniciples for evaluating biotechnolgy companies from a seasoned wall street/ medicine hybrid. But Duarte gives too much general investement advice, and too little advice specific to biotechnology investing…
Rating: 1 / 5